Back to Search Start Over

Extracellular proteases and their inhibitors ingenetic diseases of the central nervous system

Authors :
Florence Molinari
Peter Sonderegger
Virginia Meskanaite
Laurence Colleaux
Arnold Munnich
Aix Marseille Université (AMU)
Génétique et épigénétique des maladies métaboliques, neurosensorielles et du développement (Inserm U781)
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Handicaps génétiques de l'enfant (Inserm U393)
Source :
Human Molecular Genetics, Human Molecular Genetics, Oxford University Press (OUP), 2012, 12 (suppl 2), pp.R195-R200. ⟨10.1093/hmg/ddg276⟩
Publication Year :
2017

Abstract

International audience; Cumulative evidence has shown that a delicate balance between serine proteases and their inhibitors is crucial for normal functioning of several biological pathways. The importance of proteases and their inhibitors is well documented in several human diseases. Among them, the best documented are hemophilia B, a genetic deficiency of the serine protease coagulation factor IX and serpinophathies. Alpha-1-antitrypsin deficiency (MIM 107400), is associated with early-onset emphysema and liver disease, while hereditary angioedema (HANE; MIM 106100) is caused by mutations in the C1 inhibitor, a serpin involved in the regulation of the complement cascade. Recently, two human genetic diseases of the central nervous system have been related to mutations in components of extracellular proteolytic systems. Here, we review the recent advances in this field.

Details

Language :
English
ISSN :
09646906 and 14602083
Database :
OpenAIRE
Journal :
Human Molecular Genetics, Human Molecular Genetics, Oxford University Press (OUP), 2012, 12 (suppl 2), pp.R195-R200. ⟨10.1093/hmg/ddg276⟩
Accession number :
edsair.doi.dedup.....882d9e26fc5cf328133e93f58f733c99
Full Text :
https://doi.org/10.1093/hmg/ddg276⟩